Takeda provides updates on its pharmacokinetic-guided prophylaxis studies at ISTH 2020, reinforcing its commitment to advancing personalized care for people with bleeding disorders

Takeda provides updates on its pharmacokinetic-guided prophylaxis studies at ISTH 2020, reinforcing its commitment to advancing personalized care for people with bleeding disorders

Takeda provides updates on its pharmacokinetic-guided prophylaxis studies at ISTH 2020, reinforcing its commitment to advancing personalized care for people with bleeding disorders

Takeda Pharmaceutical Company Limited today announced that 13 abstracts are being presented from the company’s Hematology portfolio and pipeline at the International Society on Thrombosis and Haemostasis 2020 Virtual Congress.